Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Digital Health|March 25, 2026
Development of a generative AI agent for family support in implementing family-based treatment for children and adolescents with anorexia nervosaMana Hanzawa, Joe Hasei, Ayumi Okada, et al.
Plos One|April 22, 2021
Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expressionToshinori Omori, Hiroshi Tazawa, Yasuaki Yamakawa, et al.
Acta Medica Okayama|April 30, 2024
p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL ExpressionTadashi Komatsubara, Hiroshi Tazawa, Joe Hasei, et al.
Molecular Cancer Therapeutics|January 15, 2013
Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cellsJoe Hasei, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.
Science Translational Medicine|October 29, 2020
Mohawk is a transcription factor that promotes meniscus cell phenotype and tissue repair and reduces osteoarthritis severityKwang Il Lee, Ramya Gamini, Merissa Olmer, et al.
Molecular Therapy. Oncology|August 7, 2024
p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell deathKoji Demiya, Hiroshi Tazawa, Hiroya Kondo, et al.
Cancers|August 10, 2024
Utilizing the Metaverse to Provide Innovative Psychosocial Support for Pediatric, Adolescent, and Young Adult Patients with Rare CancerJoe Hasei, Hisashi Ishida, Hideki Katayama, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2025
Osteosarcoma cell-derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophagesHiroya Kondo, Hiroshi Tazawa, Tomohiro Fujiwara, et al.
Cancer Science|July 8, 2017
Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destructionYasuaki Yamakawa, Hiroshi Tazawa, Joe Hasei, et al.
Scientific Reports|July 1, 2016
Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomasShuhei Osaki, Hiroshi Tazawa, Joe Hasei, et al.
Pageof 4